Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

분류되지 않음
May 15, 2018

Why is life sciences data integration so hard?
분류되지 않음
May 2, 2018

Novo Nordisk’s Ozempic: Launch was late but sales forecasts climbing
분류되지 않음
May 1, 2018

Algeria, Morocco and Tunisia changing their regulatory landscape?
분류되지 않음
April 25, 2018

ESMO session explores CDK inhibition and cell cycle modulation in cancer
분류되지 않음
April 19, 2018

Partnering to innovate creates ‘window of opportunity’ in biopharma sourcing and procurement
분류되지 않음
April 18, 2018

GSK’s Shingrix set to become the market leading shingles vaccine
분류되지 않음
April 12, 2018

NMEs, notable line extensions and worldwide approvals: A comprehensive look at the year’s new drugs & biologics, 2017
분류되지 않음
April 3, 2018

Women have their say as all-female panel talks biopharma investment, technology trends
분류되지 않음
March 29, 2018

Oncology, driven by the promise of IO, dominates biopharma deals landscape
분류되지 않음
March 27, 2018

The opioid crisis: a 21st century pain
분류되지 않음
March 22, 2018

Record number of blockbusters forecast for 2018 launch as the pace of pharmaceutical innovation accelerates
분류되지 않음
March 20, 2018

Fast-forward: Larry Liberti on the evolving landscape of pharma regulation
분류되지 않음
March 15, 2018

Changing product mix, shifting geography drive sourcing and manufacturing outlook
분류되지 않음
March 6, 2018

Generics industry sets record for U.S. approvals, has ‘nothing to apologize for’
분류되지 않음
February 28, 2018

Diagnosis and management of rare disorders: The example of Huntington’s disease